Budget 2024: Contemplating HPV Vaccine for Cervical Cancer – FM

Cancer vaccines will become more expensive after the government considers adding the human papillomavirus (HPV) vaccine to the national immunization program

Piramal Pharma Revenue Rises 14% at Rs 1,959 Crore in Q3

Piramal Pharma Ltd detailed a 14% year-on-year ascend in its united income from tasks to ₹1,959 crore in the December finished quarter (Q3FY24), driven areas of strength for by across its verticals.

Glenmark and Pfizer Partner To Unveil Abrocitinib in India

Glenmark said it has collaborated with Pfizer to send off abrocitinib in India utilized for treatment of moderate-to-extreme atopic dermatitis (Promotion). Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and...

QIAGEN Launches QIAstat-Dx Syndrome Tests in India

QIAGEN has launched two disease test panels for its QIAstat-Dx device in India, including the gastrointestinal panel two and meningitis/encephalitis panel

Fresenius Kabi Launches Posaconazole Injection for Fungal Infections

Fresenius Kabi is posaconazole, an alternative to Noxafil, which treats or prevents severe fungal infections in adults and children at risk of developing fungal infections due to a weakened immune system.

Ichnos Glenmark Innovation: Accelerating Cancer Drug Discovery

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-focused global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), an international clinical technology subsidiary, announced the launch of its partnership, Ichnos Glenmark Innovation.

Bajaj Finserv Health Acquires Vidal Healthcare for Rs 325 Crore

Bajaj Finserv Health, a wholly owned subsidiary of Bajaj Finserv, acquired the entire stake in Vidal Healthcare Services for an enterprise value of Rs 325 crore.

Sutton Borough Chooses Aviva, Socius for Cancer Research Hub

The London Borough of Sutton has confirmed that it has chosen insurer Aviva and developer Socius as partners to progress the development of a world-leading site for cancer research and treatment at the London Cancer Hub (LCH) in Sutton, London

Call for More Investigator-Initiated Clinical Trials in Indian Oncology

India needs investigator-led clinical trials, especially in oncology. Dr BS Ajaikumar, chairman of HealthCare Global Enterprises, said there should be more opportunities to conduct cross-sectional studies.

Dr Reddy's Q3 Net Profit Soars 11% To rs 1,378.9 Crore

Dr Reddy's Research facilities Ltd. (DRL) beat expert assumptions to report a net profit of ₹1,378.9 crore in the second from last quarter finished December (Q3FY24), a 11% year-on-year rise, helped by piece of the pie gains. During that time, the...

© 2025 India Pharma Outlook. All Rights Reserved.